An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease.
Saved in:
| Title: | An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. |
|---|---|
| Authors: | Reading CL; BioVie Inc., Carson City, NV, United States., Yan J; BioVie Inc., Carson City, NV, United States., Testa MA; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, United States., Simonson DC; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Javaid H; Hurdle.bio/Chronomics Ltd., London, United Kingdom., Schmunk L; Hurdle.bio/Chronomics Ltd., London, United Kingdom., Martin-Herranz DE; Hurdle.bio/Chronomics Ltd., London, United Kingdom., Brooke R; Epigenetic Clock Development Foundation, Torrance, CA, United States., Gordevicius J; Epigenetic Clock Development Foundation, Torrance, CA, United States., Zhang J; Princeton Pharmatech, Princeton, NJ, United States., Yuan H; Princeton Pharmatech, Princeton, NJ, United States., Ahlem C; BioVie Inc., Carson City, NV, United States., Wang L; BioVie Inc., Carson City, NV, United States., Markham P; BioVie Inc., Carson City, NV, United States., Osman N; BioVie Inc., Carson City, NV, United States., O'Quinn S; BioVie Inc., Carson City, NV, United States., Palumbo J; BioVie Inc., Carson City, NV, United States. |
| Source: | Frontiers in neuroscience [Front Neurosci] 2025 May 02; Vol. 19, pp. 1516746. Date of Electronic Publication: 2025 May 02 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40386807 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reading+CL%22">Reading CL</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Yan+J%22">Yan J</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Testa+MA%22">Testa MA</searchLink>; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Simonson+DC%22">Simonson DC</searchLink>; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Javaid+H%22">Javaid H</searchLink>; Hurdle.bio/Chronomics Ltd., London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schmunk+L%22">Schmunk L</searchLink>; Hurdle.bio/Chronomics Ltd., London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martin-Herranz+DE%22">Martin-Herranz DE</searchLink>; Hurdle.bio/Chronomics Ltd., London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brooke+R%22">Brooke R</searchLink>; Epigenetic Clock Development Foundation, Torrance, CA, United States.<br /><searchLink fieldCode="AU" term="%22Gordevicius+J%22">Gordevicius J</searchLink>; Epigenetic Clock Development Foundation, Torrance, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Princeton Pharmatech, Princeton, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Yuan+H%22">Yuan H</searchLink>; Princeton Pharmatech, Princeton, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Ahlem+C%22">Ahlem C</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Markham+P%22">Markham P</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Osman+N%22">Osman N</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22O'Quinn+S%22">O'Quinn S</searchLink>; BioVie Inc., Carson City, NV, United States.<br /><searchLink fieldCode="AU" term="%22Palumbo+J%22">Palumbo J</searchLink>; BioVie Inc., Carson City, NV, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101478481%22">Frontiers in neuroscience</searchLink> [Front Neurosci] 2025 May 02; Vol. 19, pp. 1516746. <i>Date of Electronic Publication: </i>2025 May 02 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101478481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1662-4548 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221662453X%22">1662453X </searchLink><i>NLM ISO Abbreviation: </i>Front Neurosci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40386807 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fnins.2025.1516746 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1516746 Titles: – TitleFull: An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reading CL – PersonEntity: Name: NameFull: Yan J – PersonEntity: Name: NameFull: Testa MA – PersonEntity: Name: NameFull: Simonson DC – PersonEntity: Name: NameFull: Javaid H – PersonEntity: Name: NameFull: Schmunk L – PersonEntity: Name: NameFull: Martin-Herranz DE – PersonEntity: Name: NameFull: Brooke R – PersonEntity: Name: NameFull: Gordevicius J – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Yuan H – PersonEntity: Name: NameFull: Ahlem C – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Markham P – PersonEntity: Name: NameFull: Osman N – PersonEntity: Name: NameFull: O'Quinn S – PersonEntity: Name: NameFull: Palumbo J IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2025 May 02 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1662-4548 Numbering: – Type: volume Value: 19 Titles: – TitleFull: Frontiers in neuroscience Type: main |
| ResultId | 1 |